Table 4 Reverse transcriptase and protease resistance profiles of five patients with detectable viral load after 24 months on second-line antiretroviral regimens
Patient | Age | Gender | Second-line ARV regimens | Duration (months) | VL24 Log10 | RT resistance profile | PR resistance profile |
|---|---|---|---|---|---|---|---|
1 | 39 | M | 3TC DDI LPV/r | 44 | 3.6 | 3TC FTC | not amplified |
2 | 37 | M | 3TC DDI LPV/r | 28 | 2.8 | not amplified | not amplified |
3 | 30 | F | 3TC DDI LPV/r | 27 | 4.4 | none | none |
4 | 42 | M | 3TC TDF LPV/r | 34 | 3.9 | ABC TDF NVP EFV | IDV SQV/r* TPV/r* |
5 | 48 | M | LPV/r fosAPV | 24 | 3.4 | NPV EFV | IDV NFV ATV LPV/r TPV/r* |